Low leucine levels in the blood enhance the pathogenicity of neonatal meningitis-causing Escherichia coli

Hao Sun, Xiaoya Li, Xinyuan Yang, Jingliang Qin, Yutao Liu, Yangyang Zheng, Qian Wang, Ruiying Liu, Hongmin Sun, Xintong Chen, Qiyue Zhang, Tianyuan Jia, Xiaoxue Wu, Lu Feng, Lei Wang () and Bin Liu ()
Additional contact information
Hao Sun: Nankai University
Xiaoya Li: Nankai University
Xinyuan Yang: Nankai University
Jingliang Qin: Nankai University
Yutao Liu: Nankai University
Yangyang Zheng: Nankai University
Qian Wang: Nankai University
Ruiying Liu: Nankai University
Hongmin Sun: Nankai University
Xintong Chen: Nankai University
Qiyue Zhang: Nankai University
Tianyuan Jia: The Second Affiliated Hospital of Southern University of Science and Technology
Xiaoxue Wu: Nankai University
Lu Feng: Nankai University
Lei Wang: Nankai University
Bin Liu: Nankai University

Nature Communications, 2025, vol. 16, issue 1, 1-16

Abstract: Abstract Neonatal bacterial meningitis is associated with substantial mortality and morbidity worldwide. Neonatal meningitis-causing Escherichia coli (NMEC) is the most common gram-negative bacteria responsible for this disease. However, the interactions of NMEC with its environment within the host are poorly understood. Here, we showed that a low level of leucine, a niche-specific signal in the blood, promotes NMEC pathogenicity by enhancing bacterial survival and replication in the blood. A low leucine level downregulates the expression of NsrP, a small RNA (sRNA) identified in this study, in NMEC in an Lrp-dependent manner. NsrP destabilizes the mRNA of the purine biosynthesis-related gene purD by direct base pairing. Decreased NsrP expression in response to low leucine levels in the blood, which is a purine-limiting environment, activates the bacterial de novo purine biosynthesis pathway, thereby enhancing bacterial pathogenicity in the host. Deletion of NsrP or purD significantly increases or decreases the development of E. coli bacteremia and meningitis in animal models, respectively. Furthermore, we showed that intravenous administration of leucine effectively reduces the development of bacteremia and meningitis caused by NMEC by blocking the Lrp-NsrP-PurD signal transduction pathway. This study provides a potential strategy for the prevention and treatment of E. coli-induced meningitis.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-57850-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-57850-2

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-57850-2

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().